Wanbury gets nod to settle debt by selling few brands

03 Jun 2019 Evaluate

Wanbury has received approval for debt settlement and fund raising plan by sale of few brands. The Board of Directors of the Company at its meeting held on June 01, 2019 has approved the same.

Wanbury is the fastest growing pharma company and has a strong presence in the domestic branded formulations.

Wanbury Share Price

214.55 3.55 (1.68%)
22-Nov-2024 12:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.75
Dr. Reddys Lab 1208.10
Cipla 1485.55
Lupin 2058.70
Zydus Lifesciences 945.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.